Saturday, December 7

Speaker

Presentation Description

Learning Objectives
8:00 - 9:00 AM Erica Holland Dr. Holland will review emergence delirium in the pediatric population and provide an update on the latest methods of prevention and treatment. 

Upon completion of this learning activity, participants should be able to:

1) Define and recognize emergence delirium in the pediatric patient

2) Predict those patients at higher risk for emergence delirium and construct an anesthetic to minimize that risk.

3) Apply therapeutic interventions to treat emergence delirium.

9:00 - 10:00 AM 

 Beverly K. Philip  More information soon...

1) To understand that ambulatory surgery ERAS recovery is a patient-focused concept.

2) To learn how specific anesthetic agents can be identified and used to promote ERAS recovery.

3) To review approaches for management of the common recovery challenges, pain and nausea.
10:30 - 11:30 AM  Daniel Bainbridge What is the best fluid in the perioperative period, ringers, saline or albumin.

1) review the benefits and risks of albumin versus crystalloid;

2) compare ringers lactate to saline for perioperative patients;

3) review the optimum fluid choice in specific patient groups (renal failure, raised ICP)
11:30 - 12:30 PM Michael Souter This presentation will encompass current logistical challenges in organ donation, the physiological consequences of brain death and how that affects subsequent donor management translating into the OR environment, alongside a brief review of the role of anesthesiology in donation after circulatory death.

After completion of this activity, the participants will be able to:

1) identify and gain insight into the growing imbalance between available organs for transplant and the expanding pool of possible recipients awaiting transplant.

2) understand brain death, it’s diagnosis, and the accompanying physiological challenges that impact upon subsequent organ donation.

3) examine the emerging possibilities for donation after circulatory death, and how anesthesiologists may be increasingly involved.
12:30 - 2:00 PM  Beverly K. Philip  

Participants will learn

* How ASA is working with members nationally and in the states to address current and emerging opportunities

* Key trends and challenges facing the specialty in the market, legislature and regulatory, nationally and in the states
2:00 PM   Women In Anesthesiology - Western Washington State

Meet and Greet with Women in Anesthesiology at The W Hotel in Trace.

 

 

Sunday, December 8

Speaker

Presentation Description

Learning Objectives
8:00 - 9:00 AM Su-Yin MacDonell Troponin can be used to identify perioperative complications beyond myocardial injury. We will discuss how troponin can be used to monitor high risk surgical patients. 

After completion of this activity, the participants will be able to:

1) Understand how troponin can be used to identify cardiac and non-cardiac perioperative complications;

2) Appreciate what perioperative complications tend to occur;

3) Develop a perioperative program 

9:00 - 10:00 AM (1) 

10:30 - 11;30 AM (2) 

 Sara Nikravan  The presentation will highlight the first publications supporting point of care ultrasound and move into the evidence support it’s use. We will also discuss the complexities of ultrasonographic evaluations and the need for consistent and formalized training. The second part of the lecture will be comprised of cases.   

1) Discuss the evidence supporting the use of POCUS

2) Learn triggers that will help steer you away from cursory qualitative assessments of volume status

3) Highlight the future directions and challenges ahead
11:30 - 12:30 PM  Katherine Bailey This presentation will review the most recent up-to-date knowledge regarding neurotoxicity and neurocognitive outcomes in pediatric anesthesia. 

1) Describe up-to-date evidence about neuro-cognitive outcomes in pediatric patients undergoing anesthesia;

2) Develop an evidence-informed approach to surgical and anesthetic planning for younger patients.

3) Introduce future research directions in pediatric anesthesia and neurotoxicity

 

Speaker Bio:

Dr. Erica Holland is a pediatric anesthesiologist at Seattle Children’s. She completed her undergraduate degree at Stanford University, followed by medical training at the Geisel School of Medicine at Dartmouth. Dr. Holland completed her internship at California Pacific Medical Center, then moved to Seattle to finish her anesthesiology residency at Virginia Mason Medical Center. Subsequently, she completed two fellowships in pediatric anesthesiology and pediatric regional anesthesia at Seattle Children’s.